OptimizeRx Co. (NASDAQ:OPRX) Receives Average Rating of “Buy” from Analysts
Shares of OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) have earned a consensus recommendation of “Buy” from the eight research firms that are presently covering the firm, MarketBeat reports. Eight equities research analysts have rated the stock with a buy rating. The average twelve-month price objective among analysts that have issued a report on the […]
More Stories
Is Lanterns Season 2 Renewed? Plot, Release Date, and Episodes
Television series by Chris Mundy: Lanterns update! Fans are excited to know the renewal status of the famous superhero series...
US Embassy Warns Americans to Reconsider Travel to Saudi Arabia Amid Houthi Strikes
By Jack Phillips The U.S. Embassy in Saudi Arabia’s capital on Tuesday issued renewed warnings about traveling to the country...
Pope Leo XIV Diagnosed With Cancer as Doctors Remove Part of His Lung
By Jill McLaughlin Pope Leo XIV was diagnosed with lung cancer following surgery to remove a section of his lung...
Third-Quarter Earnings Start This Week: Prepare for More Positive Surprises
By Louis Navellier Later this week, financial stocks will launch their third-quarter earnings season, and I expect most of the...
10 Most Anticipated Horror Games Coming Soon in 2026-2027
There is a bunching up of horror titles in the latter part of 2026 and the early months of 2027,...
Supreme Court to Hear Dispute Over Access to DOGE Records
By Matthew Vadum The Supreme Court on Oct. 13 agreed to decide whether a federal judge improperly ordered broad discovery...